Cervilenz (Chagrin Falls, OH) a development-stage device company focused on the a disposable to identify and manage pregnant women at high risk for preterm birth, closed an $8.35M Series A financing. Participants include Arboretum Ventures and Chrysalis Ventures.

Cleveland Heartlab (Cleveland, OH) a commercial-stage specialty clinical laboratory and disease management company focused on assessing cardiovascular risk, closed a $18.4M Series B financing. Participants include Excel Venture Management and HealthCare Ventures.
Thanx for your patience as we catch-up.

NanoDetection Technology (Cincinnati, OH) a development-stage in vitro poc diagnostic platform focused on uses in healthcare, food safety and bioterrorism, closed a $2.3M Series A financing. Participants include CincyTech.
Thanx for your patience as we catch-up.

SironRx Therapeutics (Cleveland, OH) a clinical-stage regenerative therapy company focused on wound repair and scarring prevention, closed a $3.4M Series A financing. Participants include North Coast Angel Fund, Cleveland Clinic, JumpStart, Fletcher Spaght Investments, Glengary, Ohio Tech Angel Fund and Early Stage Partners.
Thanx for your patience as we catch-up.

NanoDetection Technology (Franklin, OH) a development-stage point-of-care diagnostic platform, closed a $2.3M Series A financing. Participants include CincyTech.

Explorys (Cleveland, OH) a development-stage medical informatics company focused on a patient population, treatment protocols and clinical outcomes intelligence platform,closed a $11.5M Series C financing. Participants include Austin Ventures, Foundation Medical Partners, Santé Ventures and Cleveland Clinic.

Akebia Therapeutics (Cincinnati, OH) a clinical-stage pharmaceutical focused on anemia and vascular disorders, closed a $22M Series B financing. Participants include Novartis Venture Fund, Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners, Sigvion Capital and AgeChem.

AssureRx Health (Mason, OH) a commercial-stage personalized medicine company focused on a pharmacogenetic platform for the determination of drug at selection and dosage, closed a $11M Series B financing. Participants include Claremont Creek Ventures, Sequoia Capital and Allos Ventures.

And cue the confetti cannon as we celebrate the 1,000th OnBioVC.com post!

AxioMed Spine (Cleveland, OH) a clinical-stage medical device company focused on lumbar disc replacement, closed a $15M Series D financing. Participants have included Thomas, McNerney & Partners, CID Equity Partners, Early Stage Partners, Investor Growth Capital, MB Venture Partners, Primus Capital Funds and Reservoir [...]

Great Lakes Pharmaceuticals (Cleveland, OH) a clinical-stage drug:device company focused on catheter-related bloodstream infection, closed a $3.1M Series B financing. Participants include Charter Life Sciences, Early Stage Partners, Ohio Tech Angels and North Coast Angel Fund.

Akebia Therapeutics (Cincinnati, OH) a clinical-stage biopharmaceutical company focused on the development of small-molecules for anemia and vascular disease, closed a $16M Series A bringing the total financing to $25M. Participants include Novartis Venture Fund, Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners and Sigvion Capital.

CerviLenz (Chagrin Falls, OH) a commercial-stage developer of a diagnostic single-use medical device for measuring cervical length to determine the risk of pre-term birth in pregnant women, closed a $4M Series A financing. Participants include Arboretum Ventures and Chrysalis Ventures.